3D Biology: The paradigm shift in next-gen drug discovery

FDA Modernization Act 2.0

Bipartisan bill signed into law allowing alternatives to animal testing for drug and biological product applications. This historic move toward animal-free testing refutes the Federal Food, Drug and Cosmetics Act (FFDCA) of 1938 mandating that all new drugs be tested in animals to protect patients from unknown toxicity. The U.S. Food and Drug Administration (FDA) can now consider alternatives for drug testing methods, like those rooted in 3D biology which oer higher predictive power and could limit the need for up to 156 million animals used in clinical testing today.

Made with FlippingBook. PDF to flipbook with ease